Pfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11

Pfizer's COVID-19 vaccine is deemed safe and effective for children aged 5-11, with a reduced dosage that still elicits a strong immune response. This development is crucial as the Delta variant has significantly affected children returning to school. Pfizer plans to submit data to the FDA by month's end, with the approval process potentially taking weeks, though efforts are being made to expedite it.

What age group is Pfizer's vaccine considered safe and effective for?

• Children aged 5 to 11

• Teens aged 12 to 15

• Children aged 2 to 4

• Adults over 18

How does the dosage for children aged 5 to 11 compare to that for teens and adults?

• It is half the amount

• It is double the amount

• It is a third of the amount

• It is the same

Why is it important for children to receive the COVID-19 vaccine?

• To prevent the spread of the Delta variant

• To reduce the need for masks

• To avoid missing school

• To eliminate the need for social distancing

What is the next step Pfizer must take for the vaccine to be used in children?

• Distribute to pharmacies

• Increase production

• Submit data to the FDA

• Conduct more trials

How long might the FDA approval process take once Pfizer submits the data?

• Over a year

• Several months

• A few weeks

• A few days